AU8951791A - Complexes of the active enantiomer of ibuprofene with cyclodextrin - Google Patents

Complexes of the active enantiomer of ibuprofene with cyclodextrin

Info

Publication number
AU8951791A
AU8951791A AU89517/91A AU8951791A AU8951791A AU 8951791 A AU8951791 A AU 8951791A AU 89517/91 A AU89517/91 A AU 89517/91A AU 8951791 A AU8951791 A AU 8951791A AU 8951791 A AU8951791 A AU 8951791A
Authority
AU
Australia
Prior art keywords
ibuprofene
cyclodextrin
complexes
active enantiomer
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU89517/91A
Inventor
Sigurd Putter
Jozsef Szejtli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medice Chem-Pharm Fabrik Putter & Co KG GmbH
Original Assignee
PUETTER MEDICE CHEM PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PUETTER MEDICE CHEM PHARM filed Critical PUETTER MEDICE CHEM PHARM
Publication of AU8951791A publication Critical patent/AU8951791A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
AU89517/91A 1990-11-30 1991-11-29 Complexes of the active enantiomer of ibuprofene with cyclodextrin Abandoned AU8951791A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4038314 1990-11-30
DE4038314A DE4038314A1 (en) 1990-11-30 1990-11-30 COMPLEXES OF THE ACTIVE ENANTIOMER OF THE IBUPROFEN WITH CYCLODEXTRIN

Publications (1)

Publication Number Publication Date
AU8951791A true AU8951791A (en) 1992-06-25

Family

ID=6419342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89517/91A Abandoned AU8951791A (en) 1990-11-30 1991-11-29 Complexes of the active enantiomer of ibuprofene with cyclodextrin

Country Status (4)

Country Link
EP (1) EP0490193A1 (en)
AU (1) AU8951791A (en)
DE (1) DE4038314A1 (en)
WO (1) WO1992009308A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688789B2 (en) * 1993-08-10 1998-03-19 Smithkline Beecham Plc Pharmaceutical composition containing a drug/beta -cyclodextrin complex in combination with an acid-base couple

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
DE19606151C2 (en) * 1996-02-20 1999-05-12 Losan Pharma Gmbh Effervescent ibuprofen preparation and process for making the same
IT1298732B1 (en) * 1998-03-13 2000-02-02 Recordati Chem Pharm ORAL PHARMACEUTICAL COMPOSITIONS ASSUMABLE WITHOUT LIQUIDS, CONTAINING INCLUSION COMPLEXES
ES2171110B1 (en) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas PHARMACEUTICAL COMPOSITION BASED ON IBUPROFEN AND PROCEDURE FOR PREPARATION.
CZ2004262A3 (en) * 2004-02-20 2005-06-15 I. Q. A., A. S. Stable, taste-acceptable syrups containing ibuprofen and process of their preparation
US20100093872A1 (en) * 2008-10-15 2010-04-15 Erimos Pharmaceuticals Llc Stable aqueous formulations of water insoluble or poorly soluble drugs
JP5977672B2 (en) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス，エセ．アー．Ｌａｂｏｒａｔｏｒｉｏ Ｄｅ Ａｐｌｉｃａｃｉｏｎｅｓ Ｆａｒｍａｃｏｄｉｎａｍｉｃａｓ，Ｓ．Ａ． Suspension for oral administration of ibuprofen ricinate
PL2253329T3 (en) * 2009-04-27 2017-08-31 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Ibuprofen lysinate oral suspension
GB201021267D0 (en) 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
CN103690474B (en) * 2013-12-04 2015-09-30 郑州大明药物科技有限公司 The preparation method of Ibuprofen cream

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0267321B1 (en) * 1986-11-14 1990-02-28 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Medicament containing ibuprofen
CA1298290C (en) * 1987-01-09 1992-03-31 Herand M. Markarian Solution ibuprofen complexes, compositions and processes for preparing the same
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
EP0406811A3 (en) * 1989-07-03 1991-08-28 Ajinomoto Co., Inc. Novel clathrate compounds and a drug comprising them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688789B2 (en) * 1993-08-10 1998-03-19 Smithkline Beecham Plc Pharmaceutical composition containing a drug/beta -cyclodextrin complex in combination with an acid-base couple

Also Published As

Publication number Publication date
DE4038314A1 (en) 1992-06-04
WO1992009308A1 (en) 1992-06-11
EP0490193A1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
AU639126B2 (en) Oxorapamycin
AU8791791A (en) Catheter with adjustable external locking bolster
AU8791591A (en) Tnf-muteins
AU7846991A (en) Aminobenzodiazepines
AU8951791A (en) Complexes of the active enantiomer of ibuprofene with cyclodextrin
AU8043491A (en) Fungicides
AU639797B2 (en) Supports for active entities
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7956191A (en) Transportsystem
AU650928B2 (en) Coated article
AU7726391A (en) Slitterscorer
AU9055391A (en) Substituted 5-aryl imidazoles
AU639966B2 (en) Bucket wheel with supporting body
AU7874291A (en) Packaging-material body
AU7566691A (en) Compostor
AU8740291A (en) 3d-spectacles
AU8494191A (en) Outer-boom crane
AU7730991A (en) Halopropargyl compounds and the use thereof as microbicides
AU4947993A (en) Combretastatin derivatives with antitumoral activity and process for the preparation thereof
AU7587991A (en) Electrodermatome
AU8311091A (en) Fin-fish farming
AU8984191A (en) Thiadiazinones
AU8043891A (en) Fungicides
AU8532591A (en) Crane
AU7922191A (en) 2-acylamino-7-chlorobenzothiazoles